Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Pfizer says EU advisory panel recommends approval for its advanced kidney cancer drug Inlyta
Pfizer says EU advisory panel recommends approval for its advanced kidney cancer drug Inlyta
Pfizer says EU advisory panel recommends approval for its advanced kidney cancer drug Inlyta
Submitted by
admin
on May 25, 2012 - 11:15am
Source:
Yahoo/AP
News Tags:
Inlyta
Pfizer
Europe
kidney cancer
Headline:
Pfizer says EU advisory panel recommends approval for its advanced kidney cancer drug Inlyta
Do Not Allow Advertisers to Use My Personal information
